register

News & Trends - MedTech & Diagnostics

Patient risk the priority in elective surgery reboot

Health Industry Hub | April 23, 2020 |

MedTech News: Patient safety and wellbeing is central to the staged return to elective surgery agreed by the National Cabinet, says Australian Private Hospitals Association’s (APHA) CEO Michael Roff.

“Private hospitals welcome the controlled return of elective surgery, which must be conducted so patients, health care workers and other hospital staff are as safe as possible. A phased reintroduction will allow hospitals to minimise risk to patients, monitor use of personal protective equipment (PPE) and ensure we maintain capacity in the system to address the pandemic if it is required.

“We must acknowledge the great work already done in the health care system and by Australians in flattening the curve and putting governments in a position to allow the reintroduction of some elective procedures.

“We agree with the National Cabinet’s approach and look forward to resuming surgeries that will have a dramatic effect on the quality of life for many Australians,” Mr Roff said.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Mr Roff stressed the importance of access to PPE to ensure safety of patients and health care workers and that the use of PPE is appropriate to the procedure, in accordance with nationally developed guidelines.

“Access to PPE is going to be a critical issue for return to elective surgery and if normal supply chains are not restored soon, private hospitals will need to be given access either to government supply chains or to the national stockpile to ensure they can provide care safely.

“For a nationally consistent approach surgical restrictions need to be eased across the private and public hospitals at the same rate. This is to ensure equity of access to available services for patients on public elective waiting lists, in addition to privately insured patients.

“We must work together, going forward, to ensure Australians are able to get the care they need and our health workforce has the PPE needed to provide that care in a safe environment,” he said.

You may also like MedTech industry collaboration on PPE supply plays key role in elective surgery resumption

You may also like PRIME Awards 2020 call for entries – recognising excellence within Australian healthcare communications


News & Trends - Pharmaceuticals

Medicines Australia and AusBiotech CEOs set agenda for the new year

Medicines Australia and AusBiotech CEOs set agenda for the new year

Health Industry Hub | January 16, 2025 |

Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]

More


News & Trends - MedTech & Diagnostics

MTAA and PTA CEOs voice outlook for the year ahead

MTAA and PTA CEOs voice outlook for the year ahead

Health Industry Hub | January 16, 2025 |

Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]

More


ESG

Boehringer Ingelheim sets sustainability benchmark in NZ

Boehringer Ingelheim sets sustainability benchmark in NZ

Health Industry Hub | January 16, 2025 |

Boehringer Ingelheim’s Auckland office has achieved a milestone in sustainability, earning the prestigious 6 Green Star Interiors certification from the […]

More


News & Trends - Pharmaceuticals

Scathing report exposes Labor’s mismanagement of the PBS

Scathing report exposes Labor’s mismanagement of the PBS

Health Industry Hub | January 16, 2025 |

The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]

More


This content is copyright protected. Please subscribe to gain access.